[HTML][HTML] Down syndrome and Alzheimer's disease: common molecular traits beyond the amyloid precursor protein

W Gomez, R Morales, V Maracaja-Coutinho… - Aging (Albany …, 2020 - ncbi.nlm.nih.gov
Alzheimer's disease (AD) is the most prevalent type of dementia. Down syndrome (DS) is the
leading genetic risk factor for Early-Onset AD, prematurely presenting the classic …

Dementia in Down syndrome: unique insights for Alzheimer disease research

IT Lott, E Head - Nature Reviews Neurology, 2019 - nature.com
Virtually all adults with Down syndrome (DS) show the neuropathological changes of
Alzheimer disease (AD) by the age of 40 years. This association is partially due to …

Aging in Down syndrome and the development of Alzheimer's disease neuropathology

E Head, IT Lott, DM Wilcock… - Current Alzheimer …, 2016 - ingentaconnect.com
Chromosome 21, triplicated in Down Syndrome, contains several genes that are thought to
play a critical role in the development of AD neuropathology. The overexpression of the …

[HTML][HTML] Plasma biomarkers for amyloid, tau, and cytokines in Down syndrome and sporadic Alzheimer's disease

CM Startin, NJ Ashton, S Hamburg, R Hithersay… - Alzheimer's research & …, 2019 - Springer
Background Down syndrome (DS), caused by chromosome 21 trisomy, is associated with an
ultra-high risk of dementia due to Alzheimer's disease (AD), driven by amyloid precursor …

Communication breaks-Down: from neurodevelopment defects to cognitive disabilities in Down syndrome

A Contestabile, F Benfenati, L Gasparini - Progress in neurobiology, 2010 - Elsevier
Down syndrome (DS) is the leading cause of genetically-defined intellectual disability and
congenital birth defects. Despite being one of the first genetic diseases identified, only …

Impact of increased APP gene dose in Down syndrome and the Dp16 mouse model

M Sawa, C Overk, A Becker, D Derse… - Alzheimer's & …, 2022 - Wiley Online Library
Abstract Introduction People with Down syndrome (DS) are predisposed to Alzheimer's
disease (AD). The amyloid hypothesis informs studies of AD. In AD‐DS, but not sporadic AD …

Clinical aspects and biomarkers of Alzheimer's disease in Down syndrome

P Zis, A Strydom - Free Radical Biology and Medicine, 2018 - Elsevier
Alzheimer's disease (AD) may affect in excess of 90% of individuals with Down syndrome
(DS) after age 60, due to duplication of the APP gene in trisomy of chromosome 21, with …

Dysfunction of autophagy and endosomal-lysosomal pathways: Roles in pathogenesis of Down syndrome and Alzheimer's Disease

DJ Colacurcio, A Pensalfini, Y Jiang… - Free Radical Biology and …, 2018 - Elsevier
Individuals with Down syndrome (DS) have an increased risk of early-onset Alzheimer's
Disease (AD), largely owing to a triplication of the APP gene, located on chromosome 21. In …

[HTML][HTML] Gene expression profiling in the adult Down syndrome brain

HE Lockstone, LW Harris, JE Swatton, MT Wayland… - Genomics, 2007 - Elsevier
The mechanisms by which trisomy 21 leads to the characteristic Down syndrome (DS)
phenotype are unclear. We used whole genome microarrays to characterize for the first time …

Association of variants within APOE, SORL1, RUNX1, BACE1 and ALDH18A1 with dementia in Alzheimer's disease in subjects with Down syndrome

A Patel, SD Rees, MA Kelly, SC Bain, AH Barnett… - Neuroscience …, 2011 - Elsevier
Background: Down syndrome (DS) is caused by either complete or partial triplication of
chromosome 21, affecting approximately 1/1000 live births, and it is widely accepted that …